Yakira Capital Management, Inc. Scynexis Inc Transaction History
Yakira Capital Management, Inc.
- $202 Million
- Q3 2025
A detailed history of Yakira Capital Management, Inc. transactions in Scynexis Inc stock. As of the latest transaction made, Yakira Capital Management, Inc. holds 189,802 shares of SCYX stock, worth $111,983. This represents 0.08% of its overall portfolio holdings.
Number of Shares
189,802
Previous 189,802
-0.0%
Holding current value
$111,983
Previous $127,000
23.62%
% of portfolio
0.08%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...